Chip Stocks Hit by Fears of China Restrictions, Eli Lilly Sinks on News of Rival Weight-loss Pill
The Rundown
00:00
Advancements in Weight Loss Drugs and Sale of Supreme Brand to Essalora Luxottica
The chapter reveals the rise in stock prices of pharmaceutical companies due to the development of weight loss pills by Roche and Pfizer, along with VF Corp's shares increasing after selling Supreme to Essalora Luxottica for $1.5 billion, signaling a lucrative market trend.
Transcript
Play full episode
